tiprankstipranks
Advertisement
Advertisement

ELVN Stock Latest News

Enliven rises 11.0%
The FlyEnliven rises 11.0%
7h ago
ELVN
Enliven price target raised to $56 from $48 at H.C. Wainwright
PremiumThe Fly
Enliven price target raised to $56 from $48 at H.C. Wainwright
13h ago
ELVN
Clear Street says Merck’s bet on TERN-701 sharpens investment case for ELVN-001
PremiumThe Fly
Clear Street says Merck’s bet on TERN-701 sharpens investment case for ELVN-001
1d ago
MRK
NVS
Video: Arm jumps as analysts react favorably to business model shift, guidance
PremiumThe Fly
Video: Arm jumps as analysts react favorably to business model shift, guidance
1d ago
ARM
MRK
Enliven up 20% after Terns Pharmaceuticals agrees to be bought by Merck
PremiumThe Fly
Enliven up 20% after Terns Pharmaceuticals agrees to be bought by Merck
1d ago
MRK
ELVN
Enliven price target raised to $45 from $41 at Mizuho
PremiumThe FlyEnliven price target raised to $45 from $41 at Mizuho
1d ago
ELVN
Enliven Therapeutics: Compelling Early ELVN-001 Data and De-Risked Development Path Support Buy Rating
Premium
Ratings
Enliven Therapeutics: Compelling Early ELVN-001 Data and De-Risked Development Path Support Buy Rating
21d ago
ELVN
Enliven Therapeutics: Compelling ELVN-001 CML Data, Strong Cash Runway Support Buy Rating
Premium
Ratings
Enliven Therapeutics: Compelling ELVN-001 CML Data, Strong Cash Runway Support Buy Rating
23d ago
ELVN
Enliven reports Q4 EPS (48c), consensus (47c)
PremiumThe Fly
Enliven reports Q4 EPS (48c), consensus (47c)
23d ago
ELVN
Enliven Therapeutics: Robust ELVN-001 CML Data, Clear Pivotal Path, and Solid Cash Runway Support Buy Rating
PremiumRatings
Enliven Therapeutics: Robust ELVN-001 CML Data, Clear Pivotal Path, and Solid Cash Runway Support Buy Rating
3M ago
ELVN
Midday Fly By: Defense stocks surge on Trump budget request
PremiumThe Fly
Midday Fly By: Defense stocks surge on Trump budget request
3M ago
F
AA
Enliven reports ‘positive’ initial Phase 1b data for ELVN-001 in CML
PremiumThe Fly
Enliven reports ‘positive’ initial Phase 1b data for ELVN-001 in CML
3M ago
ELVN
Enliven announces expected 2026 clinical milestones for ELVN-001
PremiumThe FlyEnliven announces expected 2026 clinical milestones for ELVN-001
3M ago
ELVN
Enliven Therapeutics appoints new board chair amid transition
Premium
Company Announcements
Enliven Therapeutics appoints new board chair amid transition
3M ago
8K
ELVN
Enliven Therapeutics Appoints Richard Fair as CEO
Premium
Company Announcements
Enliven Therapeutics Appoints Richard Fair as CEO
4M ago
8K
ELVN
Enliven announces the appointment of Fair as CEO
PremiumThe Fly
Enliven announces the appointment of Fair as CEO
4M ago
ELVN
Enliven Therapeutics: Strategic Advancements and Promising Clinical Progress Support Buy Rating
PremiumRatings
Enliven Therapeutics: Strategic Advancements and Promising Clinical Progress Support Buy Rating
4M ago
ELVN
Enliven Therapeutics: Promising Financial Discipline and Strategic Positioning Justify Buy Rating
PremiumRatings
Enliven Therapeutics: Promising Financial Discipline and Strategic Positioning Justify Buy Rating
4M ago
ELVN
Enliven Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Enliven Therapeutics Reports Q3 2025 Financial Results
4M ago
ELVN
Promising Future for Enliven Therapeutics: Buy Rating Backed by Strong Phase 1 Data and Financial Stability
PremiumRatingsPromising Future for Enliven Therapeutics: Buy Rating Backed by Strong Phase 1 Data and Financial Stability
4M ago
ELVN
Enliven reports Q3 EPS (32c) vs. (48c) last year
Premium
The Fly
Enliven reports Q3 EPS (32c) vs. (48c) last year
4M ago
ELVN
Enliven Therapeutics: Strategic Positioning and Promising Data Justify Buy Rating
Premium
Ratings
Enliven Therapeutics: Strategic Positioning and Promising Data Justify Buy Rating
5M ago
ELVN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >